India's most comprehensive portal on pharmaceutical News, …
Nov 6, 2024 · Pharmabiz.com is a comprehensive online portal for Indian pharma industry, covering news, tenders, projects, stocks, drugs, medicines, laws, documents, events, company profiles and more. Find the latest updates on pharma sector, US FDA, export-import, rare diseases, Alzheimer's, diabetes and other topics.
US FDA accepts Bayer’s NDA for elinzanetant to treat moderate-to …
Oct 11, 2024 · US FDA accepts Bayer’s NDA for elinzanetant to treat moderate-to-severe VMS associated with menopause: Berlin Friday, October 11, 2024, 11:00 Hrs [IST]
Ten popular brands of top drug cos are irrational or non-essential: …
The National Commission on Macroeconomics and Health in its report submitted to the government has said that 10 out of 25 top selling brands of medicines in India are irrational, non-essential or hazardous.
US FDA accepts CytoSorbents’ DrugSorb-ATR De Novo application …
Oct 24, 2024 · US FDA accepts CytoSorbents’ DrugSorb-ATR De Novo application to reduce the severity of CABG-related bleeding due to ticagrelor and initiates substantive review
Dept of Ayush approves use of additives, preservatives, etc. in ASU ...
After dilly dallying on the issue for a long, the Department of Ayush has finally approved the use of additives, preservatives, antioxidants, flavouring agents, sweeteners, chelating agents, etc. in Ayurveda, Siddha and Unani (ASU) drugs.
Pfizer’s Hympavzi receives US FDA approval to treat adults and ...
Oct 14, 2024 · Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors: New York Monday, October 14, 2024, 18:00 Hrs [IST]
Frequency: Weekly (Goes into printing every Tuesday; On stands …
Chronicle Pharmabiz is a weekly magazine that covers the latest developments and trends in the pharma industry across South Asia. It provides news, analysis, features, interviews, and profiles of pharma professionals, companies, and products.
Akums Drugs launches dual-action heartburn relief chewable …
Oct 10, 2024 · Akums Drugs launches dual-action heartburn relief chewable tablets for India: Our Bureau, Mumbai Thursday, October 10, 2024, 15:45 Hrs [IST] Akums Drugs and Pharmaceuticals, largest India focused CDMO proudly introduces dual-action heartburn relief chewable tablet, combining famotidine, calcium carbonate, and magnesium hydroxide.
Accord BioPharma receives US FDA approval for Imuldosa, a …
Oct 14, 2024 · Accord BioPharma, Inc., the US specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that the US Food and Drug Administration (FDA) has approved Imuldosa (ustekinumab-srlf), a biosimilar to Stelara (ustekinumab ...
DoP upholds ceiling price fixation of 18 formulations, refers back 3 …
Oct 14, 2024 · The Department of Pharmaceuticals (DoP) has upheld the decision of the drug price regulator and rejected review applications filed by drug major Abbott to reconsider the ceiling prices of a total of 18 formulations, while allowing the applications on three formulations where the revised Price to ...